COVID-19 Vaccines and Therapeutics

Since the start of the COVID-19 pandemic, a remarkable research and innovation effort has gone into combating the SARS-CoV-2 virus and COVID-19 disease. In response, WIPO published two patent landscape reports on COVID-19 vaccines and therapeutics.

The first report, "COVID-19-related vaccines and therapeutics, preliminary insights on related patenting activity during the pandemic" analyzed related patent filings from the beginning of 2020 through September 2021, providing early observations on patenting activity in the field of COVID-19 vaccines and therapeutics.

The second report, "COVID-19 Vaccines and Therapeutics, insights into related patenting activity throughout the pandemic", examined related patent filings from January 2020 through September 2022, providing a comprehensive review of patenting activity and building on insights from the first WIPO COVID-19 Patent Landscape Report.

Watch our launch event where we have invited experts from WHO, WTO, MPP, WIPO, and CAS to discuss recent developments in technologies related to various vaccine platforms and therapeutics targeting COVID-19, as well as partnerships and collaborations in research and development (R&D).